nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGB—coronary artery disease	0.379	0.661	CbGaD
Sucralfate—FGF2—coronary artery disease	0.169	0.295	CbGaD
Sucralfate—ALB—Pitavastatin—coronary artery disease	0.0332	0.19	CbGbCtD
Sucralfate—ALB—Valsartan—coronary artery disease	0.0323	0.185	CbGbCtD
Sucralfate—ALB—coronary artery disease	0.0249	0.0434	CbGaD
Sucralfate—ALB—Rosuvastatin—coronary artery disease	0.0244	0.14	CbGbCtD
Sucralfate—ALB—Acetylsalicylic acid—coronary artery disease	0.0238	0.136	CbGbCtD
Sucralfate—ALB—Captopril—coronary artery disease	0.0235	0.135	CbGbCtD
Sucralfate—ALB—Furosemide—coronary artery disease	0.0189	0.108	CbGbCtD
Sucralfate—ALB—Losartan—coronary artery disease	0.0185	0.106	CbGbCtD
Sucralfate—EGF—endothelium—coronary artery disease	0.00355	0.152	CbGeAlD
Sucralfate—EGF—Rosuvastatin—Pitavastatin—coronary artery disease	0.00354	1	CbGdCrCtD
Sucralfate—Haemolysis—Clopidogrel—coronary artery disease	0.0034	0.0872	CcSEcCtD
Sucralfate—Haemolysis—Enalapril—coronary artery disease	0.00276	0.0709	CcSEcCtD
Sucralfate—FGB—heart—coronary artery disease	0.00247	0.106	CbGeAlD
Sucralfate—Haemolysis—Losartan—coronary artery disease	0.00241	0.0619	CcSEcCtD
Sucralfate—FGB—cardiovascular system—coronary artery disease	0.00233	0.1	CbGeAlD
Sucralfate—FGA—heart—coronary artery disease	0.00212	0.091	CbGeAlD
Sucralfate—FGA—cardiovascular system—coronary artery disease	0.002	0.0858	CbGeAlD
Sucralfate—Lung disorder—Ticagrelor—coronary artery disease	0.00199	0.051	CcSEcCtD
Sucralfate—FGB—blood—coronary artery disease	0.00185	0.0793	CbGeAlD
Sucralfate—FGA—blood—coronary artery disease	0.00158	0.0679	CbGeAlD
Sucralfate—EGF—heart—coronary artery disease	0.00155	0.0664	CbGeAlD
Sucralfate—EGF—cardiovascular system—coronary artery disease	0.00146	0.0627	CbGeAlD
Sucralfate—FGF2—heart—coronary artery disease	0.00136	0.0586	CbGeAlD
Sucralfate—EGF—cardiac atrium—coronary artery disease	0.00132	0.0568	CbGeAlD
Sucralfate—Lung disorder—Niacin—coronary artery disease	0.0013	0.0334	CcSEcCtD
Sucralfate—Lung disorder—Telmisartan—coronary artery disease	0.00122	0.0314	CcSEcCtD
Sucralfate—EGF—blood—coronary artery disease	0.00115	0.0496	CbGeAlD
Sucralfate—Fluid overload—Lisinopril—coronary artery disease	0.00096	0.0246	CcSEcCtD
Sucralfate—Phlebitis—Fenofibrate—coronary artery disease	0.000927	0.0238	CcSEcCtD
Sucralfate—Oedema—Tirofiban—coronary artery disease	0.00085	0.0218	CcSEcCtD
Sucralfate—Hyponatraemia—Eplerenone—coronary artery disease	0.000752	0.0193	CcSEcCtD
Sucralfate—Hyponatraemia—Valsartan—coronary artery disease	0.000692	0.0177	CcSEcCtD
Sucralfate—Hyponatraemia—Olmesartan—coronary artery disease	0.000688	0.0176	CcSEcCtD
Sucralfate—Body temperature increased—Tirofiban—coronary artery disease	0.000672	0.0172	CcSEcCtD
Sucralfate—Hyponatraemia—Trandolapril—coronary artery disease	0.000643	0.0165	CcSEcCtD
Sucralfate—Hyponatraemia—Enalapril—coronary artery disease	0.00064	0.0164	CcSEcCtD
Sucralfate—Hyponatraemia—Captopril—coronary artery disease	0.000614	0.0157	CcSEcCtD
Sucralfate—Hyponatraemia—Perindopril—coronary artery disease	0.000596	0.0153	CcSEcCtD
Sucralfate—Hyponatraemia—Furosemide—coronary artery disease	0.00058	0.0149	CcSEcCtD
Sucralfate—Hyponatraemia—Losartan—coronary artery disease	0.000559	0.0143	CcSEcCtD
Sucralfate—ALB—heart—coronary artery disease	0.000534	0.023	CbGeAlD
Sucralfate—Oedema—Gemfibrozil—coronary artery disease	0.000514	0.0132	CcSEcCtD
Sucralfate—Hyponatraemia—Ramipril—coronary artery disease	0.00048	0.0123	CcSEcCtD
Sucralfate—Body temperature increased—Penbutolol—coronary artery disease	0.000477	0.0122	CcSEcCtD
Sucralfate—Infection—Rosuvastatin—coronary artery disease	0.000449	0.0115	CcSEcCtD
Sucralfate—Hyponatraemia—Lisinopril—coronary artery disease	0.000435	0.0112	CcSEcCtD
Sucralfate—Body temperature increased—Ticagrelor—coronary artery disease	0.000397	0.0102	CcSEcCtD
Sucralfate—Oedema—Fenofibrate—coronary artery disease	0.000393	0.0101	CcSEcCtD
Sucralfate—Infection—Fenofibrate—coronary artery disease	0.00039	0.01	CcSEcCtD
Sucralfate—Oedema—Clopidogrel—coronary artery disease	0.000386	0.00989	CcSEcCtD
Sucralfate—Infection—Clopidogrel—coronary artery disease	0.000383	0.00983	CcSEcCtD
Sucralfate—Infection—Lovastatin—coronary artery disease	0.000381	0.00976	CcSEcCtD
Sucralfate—Infection—Ezetimibe—coronary artery disease	0.000373	0.00958	CcSEcCtD
Sucralfate—Infection—Eplerenone—coronary artery disease	0.000366	0.00937	CcSEcCtD
Sucralfate—Oedema—Simvastatin—coronary artery disease	0.000359	0.00919	CcSEcCtD
Sucralfate—Infection—Simvastatin—coronary artery disease	0.000356	0.00913	CcSEcCtD
Sucralfate—Oedema—Valsartan—coronary artery disease	0.000339	0.00868	CcSEcCtD
Sucralfate—Oedema—Olmesartan—coronary artery disease	0.000337	0.00864	CcSEcCtD
Sucralfate—Infection—Valsartan—coronary artery disease	0.000336	0.00862	CcSEcCtD
Sucralfate—Infection—Olmesartan—coronary artery disease	0.000335	0.00858	CcSEcCtD
Sucralfate—Oedema—Niacin—coronary artery disease	0.000329	0.00844	CcSEcCtD
Sucralfate—Oedema—Pravastatin—coronary artery disease	0.000324	0.00831	CcSEcCtD
Sucralfate—Infection—Pravastatin—coronary artery disease	0.000322	0.00826	CcSEcCtD
Sucralfate—Oedema—Trandolapril—coronary artery disease	0.000315	0.00807	CcSEcCtD
Sucralfate—Oedema—Enalapril—coronary artery disease	0.000314	0.00804	CcSEcCtD
Sucralfate—Infection—Trandolapril—coronary artery disease	0.000313	0.00802	CcSEcCtD
Sucralfate—Body temperature increased—Fenofibrate—coronary artery disease	0.00031	0.00796	CcSEcCtD
Sucralfate—Oedema—Telmisartan—coronary artery disease	0.000309	0.00793	CcSEcCtD
Sucralfate—Infection—Telmisartan—coronary artery disease	0.000307	0.00788	CcSEcCtD
Sucralfate—Body temperature increased—Clopidogrel—coronary artery disease	0.000305	0.00782	CcSEcCtD
Sucralfate—Body temperature increased—Lovastatin—coronary artery disease	0.000303	0.00777	CcSEcCtD
Sucralfate—Body temperature increased—Ezetimibe—coronary artery disease	0.000297	0.00762	CcSEcCtD
Sucralfate—Oedema—Perindopril—coronary artery disease	0.000292	0.00749	CcSEcCtD
Sucralfate—Body temperature increased—Eplerenone—coronary artery disease	0.000291	0.00746	CcSEcCtD
Sucralfate—Body temperature increased—Simvastatin—coronary artery disease	0.000283	0.00727	CcSEcCtD
Sucralfate—Oedema—Losartan—coronary artery disease	0.000274	0.00702	CcSEcCtD
Sucralfate—Infection—Losartan—coronary artery disease	0.000272	0.00698	CcSEcCtD
Sucralfate—Body temperature increased—Olmesartan—coronary artery disease	0.000266	0.00683	CcSEcCtD
Sucralfate—Body temperature increased—Niacin—coronary artery disease	0.00026	0.00667	CcSEcCtD
Sucralfate—Body temperature increased—Pravastatin—coronary artery disease	0.000256	0.00657	CcSEcCtD
Sucralfate—Body temperature increased—Trandolapril—coronary artery disease	0.000249	0.00638	CcSEcCtD
Sucralfate—Body temperature increased—Enalapril—coronary artery disease	0.000248	0.00635	CcSEcCtD
Sucralfate—Body temperature increased—Telmisartan—coronary artery disease	0.000244	0.00627	CcSEcCtD
Sucralfate—Body temperature increased—Captopril—coronary artery disease	0.000238	0.00609	CcSEcCtD
Sucralfate—Oedema—Ramipril—coronary artery disease	0.000235	0.00602	CcSEcCtD
Sucralfate—Body temperature increased—Perindopril—coronary artery disease	0.000231	0.00592	CcSEcCtD
Sucralfate—Oedema—Timolol—coronary artery disease	0.00023	0.00589	CcSEcCtD
Sucralfate—Infection—Timolol—coronary artery disease	0.000228	0.00585	CcSEcCtD
Sucralfate—Body temperature increased—Furosemide—coronary artery disease	0.000224	0.00575	CcSEcCtD
Sucralfate—Body temperature increased—Losartan—coronary artery disease	0.000216	0.00555	CcSEcCtD
Sucralfate—Oedema—Lisinopril—coronary artery disease	0.000213	0.00546	CcSEcCtD
Sucralfate—Infection—Lisinopril—coronary artery disease	0.000212	0.00542	CcSEcCtD
Sucralfate—Body temperature increased—Ramipril—coronary artery disease	0.000186	0.00476	CcSEcCtD
Sucralfate—Body temperature increased—Timolol—coronary artery disease	0.000181	0.00465	CcSEcCtD
Sucralfate—Body temperature increased—Lisinopril—coronary artery disease	0.000168	0.00432	CcSEcCtD
Sucralfate—FGF2—Developmental Biology—TNF—coronary artery disease	2.45e-06	1.32e-05	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—coronary artery disease	2.44e-06	1.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADRB2—coronary artery disease	2.42e-06	1.31e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GSK3B—coronary artery disease	2.41e-06	1.3e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—coronary artery disease	2.41e-06	1.3e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—coronary artery disease	2.41e-06	1.3e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRKCE—coronary artery disease	2.39e-06	1.29e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC27A1—coronary artery disease	2.39e-06	1.29e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—POMC—coronary artery disease	2.39e-06	1.29e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CREB1—coronary artery disease	2.39e-06	1.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SOCS1—coronary artery disease	2.39e-06	1.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—S100B—coronary artery disease	2.38e-06	1.28e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—coronary artery disease	2.38e-06	1.28e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOB—coronary artery disease	2.37e-06	1.27e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6ST—coronary artery disease	2.36e-06	1.27e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—GSK3B—coronary artery disease	2.36e-06	1.27e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SOCS3—coronary artery disease	2.36e-06	1.27e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CPT1B—coronary artery disease	2.34e-06	1.26e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LCAT—coronary artery disease	2.34e-06	1.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS2—coronary artery disease	2.34e-06	1.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CREB1—coronary artery disease	2.34e-06	1.26e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL2—coronary artery disease	2.34e-06	1.26e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6R—coronary artery disease	2.33e-06	1.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KITLG—coronary artery disease	2.33e-06	1.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFBR2—coronary artery disease	2.33e-06	1.25e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	2.32e-06	1.25e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HGF—coronary artery disease	2.3e-06	1.24e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA4—coronary artery disease	2.3e-06	1.24e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1—coronary artery disease	2.3e-06	1.24e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6R—coronary artery disease	2.28e-06	1.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—STAT5A—coronary artery disease	2.28e-06	1.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP3—coronary artery disease	2.28e-06	1.23e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CSF2—coronary artery disease	2.28e-06	1.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MAPK1—coronary artery disease	2.27e-06	1.22e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—KIT—coronary artery disease	2.27e-06	1.22e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.26e-06	1.22e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—coronary artery disease	2.25e-06	1.21e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PDHA1—coronary artery disease	2.22e-06	1.2e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCLM—coronary artery disease	2.22e-06	1.2e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MAPK1—coronary artery disease	2.21e-06	1.19e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—coronary artery disease	2.21e-06	1.19e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—coronary artery disease	2.21e-06	1.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOB—coronary artery disease	2.2e-06	1.19e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—coronary artery disease	2.19e-06	1.18e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SERPINE1—coronary artery disease	2.18e-06	1.18e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGB3—coronary artery disease	2.18e-06	1.18e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—GSK3B—coronary artery disease	2.18e-06	1.17e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MAPK1—coronary artery disease	2.17e-06	1.17e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MAPK1—coronary artery disease	2.17e-06	1.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EDN1—coronary artery disease	2.16e-06	1.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CREB1—coronary artery disease	2.16e-06	1.16e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.15e-06	1.16e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP11B2—coronary artery disease	2.15e-06	1.16e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TXNRD1—coronary artery disease	2.15e-06	1.16e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL5—coronary artery disease	2.15e-06	1.16e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CD36—coronary artery disease	2.15e-06	1.16e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.14e-06	1.15e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC22A3—coronary artery disease	2.12e-06	1.14e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PPP2CA—coronary artery disease	2.12e-06	1.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CSF2—coronary artery disease	2.12e-06	1.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF1—coronary artery disease	2.12e-06	1.14e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF2—coronary artery disease	2.11e-06	1.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6R—coronary artery disease	2.11e-06	1.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LPL—coronary artery disease	2.1e-06	1.13e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—MAPK1—coronary artery disease	2.09e-06	1.13e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ARNTL—coronary artery disease	2.09e-06	1.13e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HADH—coronary artery disease	2.09e-06	1.13e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—coronary artery disease	2.08e-06	1.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RPS6KB1—coronary artery disease	2.08e-06	1.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MEF2C—coronary artery disease	2.08e-06	1.12e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PRKCD—coronary artery disease	2.08e-06	1.12e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.06e-06	1.11e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	2.05e-06	1.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ITGB3—coronary artery disease	2.03e-06	1.09e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—JAK2—coronary artery disease	2.03e-06	1.09e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.01e-06	1.08e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	1.98e-06	1.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—JAK2—coronary artery disease	1.98e-06	1.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLA2G2A—coronary artery disease	1.98e-06	1.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX2—coronary artery disease	1.98e-06	1.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA2—coronary artery disease	1.98e-06	1.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—coronary artery disease	1.98e-06	1.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—SERPINE1—coronary artery disease	1.97e-06	1.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PIK3CA—coronary artery disease	1.97e-06	1.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PPP2CA—coronary artery disease	1.97e-06	1.06e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—coronary artery disease	1.97e-06	1.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2—coronary artery disease	1.96e-06	1.06e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MMP1—coronary artery disease	1.96e-06	1.05e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HK1—coronary artery disease	1.96e-06	1.05e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SULT1A1—coronary artery disease	1.96e-06	1.05e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX4—coronary artery disease	1.96e-06	1.05e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCG5—coronary artery disease	1.96e-06	1.05e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.95e-06	1.05e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRKCD—coronary artery disease	1.94e-06	1.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HADHA—coronary artery disease	1.93e-06	1.04e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—MAPK1—coronary artery disease	1.93e-06	1.04e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLAU—coronary artery disease	1.92e-06	1.03e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PIK3CA—coronary artery disease	1.92e-06	1.03e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTA1—coronary artery disease	1.91e-06	1.03e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR2A—coronary artery disease	1.89e-06	1.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PIK3CA—coronary artery disease	1.89e-06	1.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—C3—coronary artery disease	1.89e-06	1.02e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LPA—coronary artery disease	1.89e-06	1.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—coronary artery disease	1.88e-06	1.01e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PIK3CA—coronary artery disease	1.88e-06	1.01e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PIK3CA—coronary artery disease	1.88e-06	1.01e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOA1—coronary artery disease	1.87e-06	1.01e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL8—coronary artery disease	1.85e-06	9.96e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MAPK14—coronary artery disease	1.84e-06	9.93e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—JAK2—coronary artery disease	1.83e-06	9.86e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLCB3—coronary artery disease	1.83e-06	9.86e-06	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—coronary artery disease	1.82e-06	9.82e-06	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	1.82e-06	9.8e-06	CbGpPWpGaD
Sucralfate—EGF—Immune System—PIK3CA—coronary artery disease	1.81e-06	9.77e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA5—coronary artery disease	1.81e-06	9.76e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HIF1A—coronary artery disease	1.8e-06	9.72e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AGT—coronary artery disease	1.8e-06	9.68e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—F2—coronary artery disease	1.79e-06	9.62e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—FN1—coronary artery disease	1.79e-06	9.62e-06	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	1.78e-06	9.62e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—P4HB—coronary artery disease	1.78e-06	9.57e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP3—coronary artery disease	1.77e-06	9.53e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS2—coronary artery disease	1.76e-06	9.51e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LEP—coronary artery disease	1.76e-06	9.49e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—coronary artery disease	1.76e-06	9.49e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.76e-06	9.48e-06	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—coronary artery disease	1.75e-06	9.4e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLA2G1B—coronary artery disease	1.74e-06	9.39e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOA1—coronary artery disease	1.74e-06	9.38e-06	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—coronary artery disease	1.74e-06	9.35e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KDR—coronary artery disease	1.72e-06	9.29e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.72e-06	9.29e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—coronary artery disease	1.72e-06	9.28e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—coronary artery disease	1.72e-06	9.28e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAPK14—coronary artery disease	1.71e-06	9.23e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.7e-06	9.18e-06	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—coronary artery disease	1.7e-06	9.15e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ESR1—coronary artery disease	1.68e-06	9.06e-06	CbGpPWpGaD
Sucralfate—EGF—Disease—PIK3CA—coronary artery disease	1.67e-06	9.02e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—coronary artery disease	1.67e-06	9.01e-06	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—coronary artery disease	1.66e-06	8.96e-06	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—coronary artery disease	1.66e-06	8.96e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FN1—coronary artery disease	1.66e-06	8.95e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—F2—coronary artery disease	1.66e-06	8.95e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6ST—coronary artery disease	1.65e-06	8.91e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—VCAN—coronary artery disease	1.64e-06	8.86e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NFKBIA—coronary artery disease	1.64e-06	8.84e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALDOA—coronary artery disease	1.63e-06	8.79e-06	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.62e-06	8.73e-06	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—coronary artery disease	1.61e-06	8.67e-06	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—coronary artery disease	1.61e-06	8.65e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KIT—coronary artery disease	1.59e-06	8.56e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DCN—coronary artery disease	1.58e-06	8.53e-06	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—coronary artery disease	1.57e-06	8.44e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF1—coronary artery disease	1.56e-06	8.43e-06	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.55e-06	8.34e-06	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—coronary artery disease	1.55e-06	8.33e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALDH2—coronary artery disease	1.54e-06	8.3e-06	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—coronary artery disease	1.54e-06	8.27e-06	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—coronary artery disease	1.54e-06	8.27e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GSK3B—coronary artery disease	1.52e-06	8.21e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—POMC—coronary artery disease	1.51e-06	8.15e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CREB1—coronary artery disease	1.51e-06	8.15e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.5e-06	8.09e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—coronary artery disease	1.5e-06	8.09e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3C2A—coronary artery disease	1.5e-06	8.09e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2C19—coronary artery disease	1.5e-06	8.09e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LIPC—coronary artery disease	1.5e-06	8.09e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HBA1—coronary artery disease	1.5e-06	8.09e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOC3—coronary artery disease	1.49e-06	8.04e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SERPINE1—coronary artery disease	1.49e-06	8.01e-06	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—coronary artery disease	1.48e-06	7.99e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LDLR—coronary artery disease	1.48e-06	7.99e-06	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—coronary artery disease	1.48e-06	7.98e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.48e-06	7.98e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL2—coronary artery disease	1.48e-06	7.97e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6R—coronary artery disease	1.48e-06	7.95e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTT1—coronary artery disease	1.47e-06	7.89e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC9A1—coronary artery disease	1.47e-06	7.89e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1—coronary artery disease	1.45e-06	7.84e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCLC—coronary artery disease	1.45e-06	7.8e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CETP—coronary artery disease	1.45e-06	7.8e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SDC1—coronary artery disease	1.43e-06	7.71e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—coronary artery disease	1.42e-06	7.64e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SERPINE1—coronary artery disease	1.38e-06	7.44e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—JAK2—coronary artery disease	1.38e-06	7.43e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—coronary artery disease	1.38e-06	7.42e-06	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—coronary artery disease	1.37e-06	7.37e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PSMB5—coronary artery disease	1.35e-06	7.29e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PSMA6—coronary artery disease	1.35e-06	7.29e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAPK1—coronary artery disease	1.35e-06	7.28e-06	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MAPK1—coronary artery disease	1.32e-06	7.13e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CTGF—coronary artery disease	1.32e-06	7.12e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—coronary artery disease	1.32e-06	7.11e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMGCR—coronary artery disease	1.31e-06	7.06e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GOT2—coronary artery disease	1.31e-06	7.06e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—JAK2—coronary artery disease	1.28e-06	6.91e-06	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.27e-06	6.82e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—coronary artery disease	1.25e-06	6.71e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAPK1—coronary artery disease	1.22e-06	6.58e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLCB1—coronary artery disease	1.2e-06	6.49e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.18e-06	6.36e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PIK3CA—coronary artery disease	1.17e-06	6.32e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL8—coronary artery disease	1.17e-06	6.3e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCA1—coronary artery disease	1.17e-06	6.29e-06	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PIK3CA—coronary artery disease	1.15e-06	6.18e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GGT1—coronary artery disease	1.13e-06	6.09e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GOT1—coronary artery disease	1.13e-06	6.09e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP3—coronary artery disease	1.12e-06	6.03e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—coronary artery disease	1.09e-06	5.87e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—PIK3CA—coronary artery disease	1.06e-06	5.71e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—coronary artery disease	1.06e-06	5.7e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—coronary artery disease	1.04e-06	5.59e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—coronary artery disease	1.02e-06	5.51e-06	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—coronary artery disease	1.02e-06	5.48e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTP1—coronary artery disease	1.02e-06	5.47e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARGC1A—coronary artery disease	1.01e-06	5.42e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMOX1—coronary artery disease	1e-06	5.4e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CAT—coronary artery disease	9.88e-07	5.32e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOB—coronary artery disease	9.59e-07	5.17e-06	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—coronary artery disease	9.58e-07	5.16e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—coronary artery disease	9.5e-07	5.12e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—coronary artery disease	9.39e-07	5.06e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—coronary artery disease	9.38e-07	5.05e-06	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—coronary artery disease	9.38e-07	5.05e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—coronary artery disease	9.33e-07	5.03e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MAPK1—coronary artery disease	9.2e-07	4.96e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LPL—coronary artery disease	9.16e-07	4.93e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX1—coronary artery disease	8.94e-07	4.81e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—coronary artery disease	8.72e-07	4.7e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CD36—coronary artery disease	8.7e-07	4.69e-06	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—coronary artery disease	8.66e-07	4.66e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPP2CA—coronary artery disease	8.59e-07	4.63e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAPK1—coronary artery disease	8.55e-07	4.61e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTHFR—coronary artery disease	8.25e-07	4.44e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PIK3CA—coronary artery disease	7.98e-07	4.3e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AGT—coronary artery disease	7.84e-07	4.22e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—coronary artery disease	7.68e-07	4.14e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA1—coronary artery disease	7.59e-07	4.09e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PIK3CA—coronary artery disease	7.42e-07	4e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.27e-07	3.92e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARG—coronary artery disease	6.69e-07	3.6e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—POMC—coronary artery disease	6.6e-07	3.55e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—coronary artery disease	6.57e-07	3.54e-06	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—coronary artery disease	6.52e-07	3.51e-06	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—coronary artery disease	6.06e-07	3.27e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—coronary artery disease	5.75e-07	3.1e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—coronary artery disease	5.26e-07	2.83e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3CA—coronary artery disease	3.24e-07	1.74e-06	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—coronary artery disease	2.64e-07	1.42e-06	CbGpPWpGaD
